260 related articles for article (PubMed ID: 9647339)
1. Long-term intraindividual variability of serum lipids in patients with type I and type II diabetes.
Tsalamandris C; Panagiotopoulos S; Allen TJ; Waldrip L; Van Gaal B; Goodall I; Jerums G
J Diabetes Complications; 1998; 12(4):208-14. PubMed ID: 9647339
[TBL] [Abstract][Full Text] [Related]
2. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
Idzior-Walus B; Mattock MB; Solnica B; Stevens L; Fuller JH;
Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes.
Marcovecchio ML; Dalton RN; Prevost AT; Acerini CL; Barrett TG; Cooper JD; Edge J; Neil A; Shield J; Widmer B; Todd JA; Dunger DB
Diabetes Care; 2009 Apr; 32(4):658-63. PubMed ID: 19171721
[TBL] [Abstract][Full Text] [Related]
5. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
[TBL] [Abstract][Full Text] [Related]
6. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA
Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific differences in blood lipids and lipid ratios in type 2 diabetic foot patients.
Yin S; Zhao P; Ai Z; Deng B; Jia W; Wang H; Zheng J
J Diabetes Investig; 2021 Dec; 12(12):2203-2211. PubMed ID: 34137504
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
[TBL] [Abstract][Full Text] [Related]
9. The long-term effects of rosiglitazone on serum lipid concentrations and body weight.
Shim WS; Do MY; Kim SK; Kim HJ; Hur KY; Kang ES; Ahn CW; Lim SK; Lee HC; Cha BS
Clin Endocrinol (Oxf); 2006 Oct; 65(4):453-9. PubMed ID: 16984237
[TBL] [Abstract][Full Text] [Related]
10. [Blood sugar and lipid metabolism parameters in diabetic retinopathy].
Schmut O; Fellinger C; Hofmann H
Klin Monbl Augenheilkd; 1985 May; 186(5):347-50. PubMed ID: 3927059
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids.
Taniguchi A; Nakai Y; Fukushima M; Teramura S; Hayashi R; Hama K; Marumoto K; Watanabe T; Yoshioka I; Sakaguchi K; Kishimoto H; Matsushita K; Okumura T; Tokuyama K; Nagasaka S; Sakai M
Metabolism; 2002 May; 51(5):539-43. PubMed ID: 11979382
[TBL] [Abstract][Full Text] [Related]
12. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
[No Abstract] [Full Text] [Related]
13. Intensive lipid-lowering strategy in patients with diabetes mellitus.
Kanters SD; Algra A; de Bruint TW; Erkelens DW; Banga JD
Diabet Med; 1999 Jun; 16(6):500-8. PubMed ID: 10391399
[TBL] [Abstract][Full Text] [Related]
14. Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review.
King AB; Armstrong DU
Diabetes Technol Ther; 2002; 4(2):145-51. PubMed ID: 12079617
[TBL] [Abstract][Full Text] [Related]
15. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
[TBL] [Abstract][Full Text] [Related]
16. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
al-Muhtaseb N; al-Yusef AR; Bajaj JS
Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a homogeneous assay with a precipitation method for the measurement of HDL cholesterol in diabetic patients.
Jensen T; Truong Q; Frandsen M; Dinesen B; Stender S
Diabetes Care; 2002 Nov; 25(11):1914-8. PubMed ID: 12401732
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
Bavirti S; Ghanaat F; Tayek JA
Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475
[TBL] [Abstract][Full Text] [Related]
20. Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes.
Maahs DM; Dabelea D; D'Agostino RB; Andrews JS; Shah AS; Crimmins N; Mayer-Davis EJ; Marcovina S; Imperatore G; Wadwa RP; Daniels SR; Reynolds K; Hamman RF; Dolan LM;
J Pediatr; 2013 Jan; 162(1):101-7.e1. PubMed ID: 22795314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
